← Browse by Condition

Medical Condition

metastatic castration resistant prostate cancer

Total Trials

9

Recruiting Now

9

Trial Phases

Phase 2, Phase 1, Phase 1, Phase 2

NCT06866938 Phase 2

Study of Re-treatment With [177Lu]Lu-PSMA in Men With Metastatic Castration Resistance Prostate Cancer

Hospices Civils de Lyon

NCT07189403 Phase 1

A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer

United States, Franc...

NCT06402331 Phase 2

FPI-2265 (225Ac-PSMA-I&T) for Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Fusion Pharmaceuticals Inc.

NCT06971211 Phase 2

Radiotherapy Combined With Fluzopanib and Abiraterone Acetate Tablets (II) Treatment for mCRPC

NCT05766371 Phase 2

Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate Cancer

University of California, San ...

NCT05521412 Phase 1, Phase 2

EValuation of radIOLigand Treatment in mEn With Metastatic Castration-resistant Prostate Cancer With [161Tb]Tb-PSMA-I&T

Peter MacCallum Cancer Centre,...

NCT07339267 Phase 1

A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer

Astellas Pharma Global Develop...

NCT06228404 EARLY_Phase 1

Clinical Study of Safety and Efficacy of Enhanced PSMA CAR- T in Refractory CRPC

Shanghai Changzheng Hospital

NCT06830850 Phase 1

A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer

Atridia Pty Ltd.